Free Trial

MarketBeat Instant News Alerts

Viemed Healthcare logo with Medical background

Viemed Healthcare (NASDAQ:VMD) Posts Quarterly Earnings Results, Meets Estimates

MarketBeat

Viemed Healthcare (NASDAQ:VMD - Get Free Report) announced its earnings results on Wednesday. The company reported $0.08 EPS for the quarter, meeting analysts' consensus estimates of $0.08. Viemed Healthcare had a return on equity of 10.56% and a net margin of 5.80%. The company had revenue of $63.06 million during the quarter, compared to analysts' expectations of $63.50 million.

NASDAQ:VMD
Read Viemed Healthcare (NASDAQ:VMD) Posts Quarterly Earnings Results, Meets Estimates
Hypermarcas logo with Medical background

Hypermarcas (OTCMKTS:HYPMY) Announces Earnings Results

MarketBeat

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

OTCMKTS:HYPMY
Read Hypermarcas (OTCMKTS:HYPMY) Announces Earnings Results
Structure Therapeutics logo with Medical background

Structure Therapeutics (NASDAQ:GPCR) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS

MarketBeat

Structure Therapeutics (NASDAQ:GPCR - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.08).

NASDAQ:GPCR
Read Structure Therapeutics (NASDAQ:GPCR) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS
Pursuit Attractions and Hospitality logo with Consumer Discretionary background

Pursuit Attractions and Hospitality (NYSE:PRSU) Releases Earnings Results, Beats Estimates By $0.10 EPS

MarketBeat

Pursuit Attractions and Hospitality (NYSE:PRSU - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.26 by $0.10. The firm had revenue of $116.74 million for the quarter, compared to the consensus estimate of $110.30 million. Pursuit Attractions and Hospitality had a net margin of 51.67% and a return on equity of 23.10%.

NYSE:PRSU
Read Pursuit Attractions and Hospitality (NYSE:PRSU) Releases Earnings Results, Beats Estimates By $0.10 EPS

CareTrust REIT (NYSE:CTRE) Announces Earnings Results, Misses Expectations By $0.02 EPS

MarketBeat

CareTrust REIT (NYSE:CTRE - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.43 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by ($0.02). CareTrust REIT had a net margin of 58.90% and a return on equity of 7.98%.

NYSE:CTRE
Read CareTrust REIT (NYSE:CTRE) Announces Earnings Results, Misses Expectations By $0.02 EPS
Lundin Mining logo with Basic Materials background

Lundin Mining (OTCMKTS:LUNMF) Hits New 1-Year High - Time to Buy?

MarketBeat

Lundin Mining (OTCMKTS:LUNMF) Reaches New 1-Year High - What's Next?

OTCMKTS:LUNMF
Read Lundin Mining (OTCMKTS:LUNMF) Hits New 1-Year High - Time to Buy?

Trending News

All MarketBeat Instant News Alerts

Celcuity logo with Medical background

Celcuity (NASDAQ:CELC) Hits New 12-Month High - Still a Buy?

MarketBeat
NASDAQ:CELC
Read Celcuity (NASDAQ:CELC) Hits New 12-Month High - Still a Buy?
Abcourt Mines logo with Basic Materials background

Abcourt Mines (CVE:ABI) Trading Up 55.6% - Here's Why

MarketBeat
CVE:ABI
Read Abcourt Mines (CVE:ABI) Trading Up 55.6% - Here's Why
Abcourt Mines logo with Basic Materials background

Abcourt Mines (CVE:ABI) Trading 55.6% Higher - What's Next?

MarketBeat
CVE:ABI
Read Abcourt Mines (CVE:ABI) Trading 55.6% Higher - What's Next?
Quadrise logo with Energy background

Quadrise (LON:QED) Trading Down 14.6% - Should You Sell?

MarketBeat
LON:QED
Read Quadrise (LON:QED) Trading Down 14.6% - Should You Sell?
Arrowhead Pharmaceuticals logo with Medical background

Royal Bank Of Canada Has Lowered Expectations for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price

MarketBeat
NASDAQ:ARWR
Read Royal Bank Of Canada Has Lowered Expectations for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price
Ascendis Pharma A/S logo with Medical background

Royal Bank Of Canada Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $230.00

MarketBeat
NASDAQ:ASND
Read Royal Bank Of Canada Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $230.00
Brookfield logo with Finance background

Royal Bank Of Canada Increases Brookfield (NYSE:BN) Price Target to $83.00

MarketBeat
NYSE:BN
Read Royal Bank Of Canada Increases Brookfield (NYSE:BN) Price Target to $83.00
Canadian Natural Resources logo with Energy background

Canadian Natural Resources (NYSE:CNQ) Given New $62.00 Price Target at Royal Bank Of Canada

MarketBeat
NYSE:CNQ
Read Canadian Natural Resources (NYSE:CNQ) Given New $62.00 Price Target at Royal Bank Of Canada
AMETEK logo with Computer and Technology background

AMETEK (NYSE:AME) Price Target Raised to $198.00

MarketBeat
NYSE:AME
Read AMETEK (NYSE:AME) Price Target Raised to $198.00
Arhaus logo with Retail/Wholesale background

Arhaus (NASDAQ:ARHS) Given New $12.50 Price Target at Morgan Stanley

MarketBeat
NASDAQ:ARHS
Read Arhaus (NASDAQ:ARHS) Given New $12.50 Price Target at Morgan Stanley
DuPont de Nemours logo with Basic Materials background

Royal Bank Of Canada Forecasts Strong Price Appreciation for DuPont de Nemours (NYSE:DD) Stock

MarketBeat
NYSE:DD
Read Royal Bank Of Canada Forecasts Strong Price Appreciation for DuPont de Nemours (NYSE:DD) Stock
Ducommun logo with Aerospace background

Ducommun (NYSE:DCO) Price Target Raised to $100.00 at Royal Bank Of Canada

MarketBeat
NYSE:DCO
Read Ducommun (NYSE:DCO) Price Target Raised to $100.00 at Royal Bank Of Canada
Brown & Brown logo with Finance background

Morgan Stanley Lowers Brown & Brown (NYSE:BRO) Price Target to $109.00

MarketBeat
NYSE:BRO
Read Morgan Stanley Lowers Brown & Brown (NYSE:BRO) Price Target to $109.00
Edgewise Therapeutics logo with Medical background

Edgewise Therapeutics (NASDAQ:EWTX) Given New $49.00 Price Target at Royal Bank Of Canada

MarketBeat
NASDAQ:EWTX
Read Edgewise Therapeutics (NASDAQ:EWTX) Given New $49.00 Price Target at Royal Bank Of Canada
Enerflex logo with Energy background

Royal Bank Of Canada Forecasts Strong Price Appreciation for Enerflex (NYSE:EFXT) Stock

MarketBeat
NYSE:EFXT
Read Royal Bank Of Canada Forecasts Strong Price Appreciation for Enerflex (NYSE:EFXT) Stock
Bumble logo with Computer and Technology background

Bumble (NASDAQ:BMBL) Price Target Raised to $6.00

MarketBeat
NASDAQ:BMBL
Read Bumble (NASDAQ:BMBL) Price Target Raised to $6.00
Expedia Group logo with Retail/Wholesale background

Royal Bank Of Canada Boosts Expedia Group (NASDAQ:EXPE) Price Target to $200.00

MarketBeat
NASDAQ:EXPE
Read Royal Bank Of Canada Boosts Expedia Group (NASDAQ:EXPE) Price Target to $200.00
Gen Digital logo with Business Services background

Royal Bank Of Canada Issues Positive Forecast for Gen Digital (NASDAQ:GEN) Stock Price

MarketBeat
NASDAQ:GEN
Read Royal Bank Of Canada Issues Positive Forecast for Gen Digital (NASDAQ:GEN) Stock Price
Carrier Global logo with Construction background

Carrier Global (NYSE:CARR) Price Target Cut to $75.00 by Analysts at Morgan Stanley

MarketBeat
NYSE:CARR
Read Carrier Global (NYSE:CARR) Price Target Cut to $75.00 by Analysts at Morgan Stanley
Gilead Sciences logo with Medical background

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $98.00 at Royal Bank Of Canada

MarketBeat
NASDAQ:GILD
Read Gilead Sciences (NASDAQ:GILD) Price Target Raised to $98.00 at Royal Bank Of Canada
Celsius logo with Consumer Staples background

Celsius (NASDAQ:CELH) Price Target Raised to $56.00 at Morgan Stanley

MarketBeat
NASDAQ:CELH
Read Celsius (NASDAQ:CELH) Price Target Raised to $56.00 at Morgan Stanley
GoDaddy logo with Computer and Technology background

GoDaddy (NYSE:GDDY) Given New $200.00 Price Target at Royal Bank Of Canada

MarketBeat
NYSE:GDDY
Read GoDaddy (NYSE:GDDY) Given New $200.00 Price Target at Royal Bank Of Canada
Helmerich & Payne logo with Energy background

Helmerich & Payne (NYSE:HP) Price Target Raised to $24.00

MarketBeat
NYSE:HP
Read Helmerich & Payne (NYSE:HP) Price Target Raised to $24.00
Insmed logo with Medical background

Insmed (NASDAQ:INSM) Price Target Raised to $120.00 at Royal Bank Of Canada

MarketBeat
NASDAQ:INSM
Read Insmed (NASDAQ:INSM) Price Target Raised to $120.00 at Royal Bank Of Canada

Featured Articles and Offers

Sector News